Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), a biopharmaceutical company, is focused on developing, manufacturing, and marketing a broad array of products based upon the shelf-stable Microcyn® Technology platform, which has been designed to help prevent and treat infections in wounds, burns and diseases. The Microcyn platform has shown capabilities of safely treating a wide range of pathogens, including antibiotic-resistant strains of bacteria such as MRSA, viruses, fungi and spores. For further information, visit the Company’s web site at www.oculusis.com.